We are live on
!
Find out more
VA
Vident Advisory Portfolio holdings
AUM
$11.7B
1-Year Est. Return
37.32%
This Fund
S&P 500
This Quarter
Est. Return
+1.93%
1 Year Est. Return
+37.32%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$11B
AUM Growth
+$516M
(+4.9%)
Cap. Flow
+$571M
Cap. Flow
% of AUM
5.2%
Top 10 Holdings %
Top 10 Hldgs %
21.29%
Holding
1,754
New
123
Increased
661
Reduced
828
Closed
128
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lockheed Martin
LMT
|
+$128M |
| 2 |
Oracle
ORCL
|
+$52M |
| 3 |
Microsoft
MSFT
|
+$42M |
| 4 |
iShares Gold Trust Micro
IAUM
|
+$38.2M |
| 5 |
Broadcom
AVGO
|
+$35.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Textron
TXT
|
+$33.7M |
| 2 |
Strategy Inc
MSTR
|
+$20.7M |
| 3 |
Palantir
PLTR
|
+$20.5M |
| 4 |
L3Harris
LHX
|
+$18.9M |
| 5 |
Northrop Grumman
NOC
|
+$16.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.87% |
| 2 | Industrials | 13.69% |
| 3 | Financials | 11.84% |
| 4 | Communication Services | 7.41% |
| 5 | Consumer Discretionary | 7.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Idexx Laboratories
IDXX
$44.3B
| $2.17M | 0.02% |
3,211
-5,470
| -63% | -$3.73M |
|
552
Haleon
HLN
$44B
| $2.17M | 0.02% |
214,286
-43,041
| -17% | -$409K |
|
553
Southern Copper
SCCO
$137B
| $2.15M | 0.02% |
15,281
-781
| -5% | -$103K |
|
554
Emerson Electric
EMR
$83.2B
| $2.15M | 0.02% |
16,185
-4,433
| -22% | -$588K |
|
555
Microchip Technology
MCHP
$41.4B
| $2.15M | 0.02% |
33,710
-493
| -1% | -$30.4K |
|
556
EQT Corp
EQT
$32.8B
| $2.15M | 0.02% |
40,020
+207
| +0.5% | +$11.6K |
|
557
Vale
VALE
$62.1B
| $2.14M | 0.02% |
164,189
+179
| +0.1% | +$2.17K |
|
558
Blue Bird Corp
BLBD
$2.34B
| $2.14M | 0.02% |
45,433
-116
| -0.3% | -$6.07K |
|
559
Hudbay
HBM
$9.63B
| $2.13M | 0.02% |
107,296
-25,099
| -19% | -$424K |
|
560
Sempra
SRE
$60.8B
| $2.12M | 0.02% |
24,055
+954
| +4% | +$86.9K |
|
|
NVO
561
Novo Nordisk
NVO
$220B
| $2.12M | 0.02% |
41,663
-4,960
| -11% | -$254K |
|
562
Lloyds Banking Group
LYG
$88.4B
| $2.12M | 0.02% |
399,308
-64,414
| -14% | -$312K |
|
563
Phillips 66
PSX
$82.3B
| $2.11M | 0.02% |
16,372
-786
| -5% | -$106K |
|
564
Quanta Services
PWR
$91.1B
| $2.1M | 0.02% |
4,987
-25
| -0.5% | -$11K |
|
565
Public Storage
PSA
$61.5B
| $2.1M | 0.02% |
8,103
-1,073
| -12% | -$300K |
|
566
DT Midstream
DTM
$14.5B
| $2.1M | 0.02% |
17,569
-3,285
| -16% | -$377K |
|
567
Target
TGT
$63.9B
| $2.1M | 0.02% |
21,494
+160
| +0.7% | +$14.7K |
|
568
National Healthcare
NHC
$3.54B
| $2.09M | 0.02% |
15,241
-2,418
| -14% | -$312K |
|
569
Corteva
CTVA
$59B
| $2.08M | 0.02% |
31,041
-48
| -0.2% | -$3.1K |
|
570
Snap-on
SNA
$21.1B
| $2.07M | 0.02% |
5,992
+106
| +2% | +$36.2K |
|
571
Zillow
Z
$7.32B
| $2.06M | 0.02% |
30,249
-499
| -2% | -$36.1K |
|
572
Ubiquiti
UI
$31.8B
| $2.06M | 0.02% |
3,728
+793
| +27% | +$502K |
|
573
United Therapeutics
UTHR
$26.5B
| $2.06M | 0.02% |
4,232
-1,276
| -23% | -$594K |
|
574
ResMed
RMD
$29.3B
| $2.06M | 0.02% |
8,554
-1,056
| -11% | -$270K |
|
575
Regeneron Pharmaceuticals
REGN
$70.6B
| $2.06M | 0.02% |
2,668
-17
| -0.6% | -$11.5K |
|
Similar funds
HTC
BCI
VIA
NYLIM
PI
UE
LC
MG
Vident Advisory's Q4 2025 Portfolio in Review
As of Q4 2025, Vident Advisory held 1,754 positions worth $11B, up 4.9% from $10.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Vident Advisory deployed $571M of net new capital in Q4 2025, opening 123 new positions and adding to 661 existing holdings. Its largest new stake was iShares MSCI Emerging Markets ex China ETF: 479,344 shares worth $34.8M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Textron, an estimated $33.7M trimmed.
- Vident Advisory's largest Q4 2025 buy was iShares MSCI Emerging Markets ex China ETF: 479,344 shares worth $34.8M.
- Vident Advisory added most to Lockheed Martin in Q4 2025, an estimated $128M increase.
- Vident Advisory's biggest Q4 2025 reduction was Textron, cutting an estimated $33.7M.
- Vident Advisory fully exited Schwab International Small-Cap Equity ETF in Q4 2025, selling an estimated $10.8M.
- Vident Advisory's ten largest holdings make up 21% of its $11B portfolio in Q4 2025.
- Vident Advisory opened 123 new positions and closed 128 in Q4 2025.
- Vident Advisory's portfolio value rose 4.9% quarter-over-quarter to $11B.
Based on Vident Advisory's 13F filing for Q4 2025, filed 18 Feb 2026.